| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.22 | 0.3 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.22 | 0.0001 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.15 | 0.6 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.3 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.095 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.088 | 0.2 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |